Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Systemic steroids effectively treated severe nail issues in a card illusionist with alopecia areata.

Vitamin D levels are not linked to alopecia areata.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Vitamin D receptor FokI gene variation is not linked to alopecia areata.

Some people with severe hair loss saw hair regrowth after a specific light and drug treatment.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Research on alopecia areata treatment has increased significantly over the past 20 years.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

The model accurately detects alopecia areata with 84.3% accuracy.

People with alopecia areata are more likely to have major depression, possibly linked to a specific genetic region.

A woman's hair mostly regrew after hair loss from the COVID-19 vaccine with treatment.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.